Skip to main content
. Author manuscript; available in PMC: 2010 Mar 17.
Published in final edited form as: Biochemistry. 2009 Mar 17;48(10):2115–2124. doi: 10.1021/bi802055v

Table 1.

Dissociation constants (Kd, μM) measured by ITC and NMR for the p53 transactivation domain with CBP KIX domain.

ITC1 NMR2
Full p53(1-61) 19 ± 5 -----
Full p53(13-61) 22 ± 5 9.3 ± 0.5
AD1 p53(14-28) n.d.3 214 ± 5
AD1 p53(14-28) (MLL site)4 ----- 211 ± 6
AD1 p53(14-28) (pKID/c-Myb site)5 ----- 242 ± 19
AD2 p53(38-61) n.d.3 79 ± 4
AD2 p53(38-61) (MLL site)4 ----- 49 ± 3
AD2 p53(38-61) (pKID/c-Myb site)5 ----- 94 ± 6
Full p53(13-57)pT18 ----- 1.8 ± 0.2
Full p53(13-57)pS20 ----- 1.3 ± 0.2
Full p53(13-57)pT18pS20 ----- 0.6 ± 0.1
MLL(2840-2858) to KIX6 2.8 ± 0.4 -----
pKID(116-149) to KIX6 1.3 ± 0.02 -----
Myb(291-315) to KIX6 10.0 ± 2.0 -----
1

ITC measurements were performed at 35°C, pH 7.0. The Kd for binding of p53(13-61) under NMR conditions (27°C, pH 6.5) is 8.5 ± 1.0 μM.

2

Kd values from NMR titrations at 27°C, pH 6.5 were obtained by global analysis.

3

n.d., not detectable by ITC

4

The titration curves of the following residues were used for the semi-global fitting: 614, 616, 620∼626, 631, 666, 669, and 670.

5

The titration curves of the following residues were used for the semi-global fitting: 595, 596, 600, 608, 609, 650, 652, 654, 655, 657, 661, and 663.

6

Kd values at 27°C, pH 7.0 (12)

HHS Vulnerability Disclosure